Stockreport

Johnson & Johnson to acquire Halda Therapeutics for $3.05bn [Yahoo! Finance]

Johnson & Johnson  (JNJ) 
Last johnson & johnson earnings: 4/14 06:31 am Check Earnings Report
US:NYSE Investor Relations: jnj.com
PDF The acquisition brings Halda's lead candidate, HLD-0915, a clinical-stage treatment for prostate cancer, into Johnson & Johnson's oncology portfolio. This once-daily [Read more]